PMOS and Insulin Resistance: A Root-Cause Approach

August 14, 2026

Polycystic Ovary Syndrome (PCOS) is increasingly recognized as a multisystem metabolic disorder rather than an isolated ovarian condition. Reflecting this evolving understanding, experts have proposed the term Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better capture the central role of insulin resistance, metabolic dysfunction, and long-term cardiometabolic risk. This one-hour continuing education program provides clinicians with an evidence-informed overview of the rationale behind the PMOS terminology, the pathophysiologic relationship between insulin resistance and reproductive dysfunction, and practical strategies for improving clinical evaluation and management. Participants will learn how to identify metabolic dysfunction beyond traditional diagnostic markers, recognize the heterogeneity of PMOS presentations, including lean phenotypes, and apply individualized lifestyle, nutrition, and supplement interventions that target underlying disease mechanisms rather than symptom management alone. Emphasis is placed on translating current evidence into practical clinical decision-making to improve both reproductive and long-term metabolic outcomes.

Target Audience

This activity is designed for pharmacists, physicians, nurse practitioners, physician assistants, registered nurses, and registered dietitians who care for patients with polycystic ovary syndrome (PCOS)/polyendocrine metabolic ovarian syndrome (PMOS), insulin resistance, metabolic dysfunction, infertility, and other women's health conditions. It is particularly relevant for clinicians practicing in primary care, family medicine, internal medicine, endocrinology, obstetrics and gynecology, lifestyle medicine, and functional or integrative medicine who want practical, evidence-informed strategies for identifying and addressing the underlying metabolic drivers of PMOS.

Learning Objectives

  • Identify diagnostic criteria and subtypes of PMOS
  • Explain how insulin resistance impacts reproductive hormones
  • Develop individualized treatment approaches using lifestyle and supplement protocols
Course summary
Available credit: 
  • 1.50 AANP Contact Hours

    Nurse Practitioners

    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Revelar Health LLC..  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.50 contact hour(s) (which includes 0.00 hour(s) of pharmacology).

  • 1.50 AAPA Category 1 CME

    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 1.50 ACPE Pharmacist

    Pharmacists
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.50 contact hours.

  • 1.50 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material, Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 ANCC Contact Hours

    Credit being awarded: 1.50 ANCC contact hours

  • 1.50 Attendance

    Credits: 1.50

  • 1.50 CDR

  • 1.50 AMA PRA Category 1 Credit™ Non-MD

    Non-Physicians Seeking AMA Credit
    AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material, Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

     

Course opens: 
08/17/2026
Course expires: 
09/30/2026
Event starts: 
08/14/2026 - 12:00pm EDT
Event ends: 
08/14/2026 - 1:30pm EDT
Cost:
$0.00
Add to calendar: 
Rating: 
0
08-14-2026-| Live Webinar
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Reviewer(s)

Leslie Edmunds

has no relevant financial relationships to disclose at this time.

Rebecca Lakofsky, BSN, RN

has no relevant financial relationships to disclose at this time.

Hannah Moore

has no relevant financial relationships to disclose at this time.

Megan Morrison, PharmD

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Melody Hartzler, PharmD, BCACP, BC-ADM, ABAAHP

has a financial relationship (Advisor) with Designs for Health;.
has a financial relationship (Speaker) with Abbott;.
has a financial relationship (Speaker) with NovoNordisk;.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Revelar Health LLC.. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

 

 

Available Credit

  • 1.50 AANP Contact Hours

    Nurse Practitioners

    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Revelar Health LLC..  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.50 contact hour(s) (which includes 0.00 hour(s) of pharmacology).

  • 1.50 AAPA Category 1 CME

    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 1.50 ACPE Pharmacist

    Pharmacists
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.50 contact hours.

  • 1.50 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material, Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 ANCC Contact Hours

    Credit being awarded: 1.50 ANCC contact hours

  • 1.50 Attendance

    Credits: 1.50

  • 1.50 CDR

  • 1.50 AMA PRA Category 1 Credit™ Non-MD

    Non-Physicians Seeking AMA Credit
    AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material, Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

     

Price

Cost:
$0.00
Please login or register to take this course.